Isoprinosine versus other antiviral drugs for chronic hepatitis B

To assess the benefits and harms of isoprinosine in the treatment of patients with chronic HBV infection.

This is a protocol.

Health topics:

Published:

30 April 2013

Authors:

Njei B, Garg SK, Kenta-Bibi E, Zhao P, Kongnyuy EJ

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Njei B, Garg SK, Kenta-Bibi E, Zhao P, Kongnyuy EJ. Isoprinosine versus other antiviral drugs for chronic hepatitis B. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010506. DOI: 10.1002/14651858.CD010506